Logo

Illumina Will Help Sanger Institute Create Hap Map

Jul 25, 2002

NEW YORK, July 25-Illumina said yesterday that it would provide SNP genotyping services for Britain's Wellcome Trust Sanger Institute to build a haplotype map of a substantial section of the human genome.

 

Illumina will develop assays for the Sanger SNP collection and use its own technology to genotype those SNPs.

 

Financial details of the arrangement were not revealed.

 

The arrangement follows a pilot genotyping study that Illumina conducted for the Sanger Institute in 2001.

 

Illumina is a San Diego-based public company.

 

For further details, see the press release.

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.